Equity Capital Markets

Company · CIK 1806540

Lycia Therapeutics, Inc.

CIK1806540 (SEC EDGAR)
Industry (SIC)2836 — Biological Products, (No Diagnostic Substances)
Incorporated inDE
Business addressCA
ListedLYCA (Nasdaq)
First annual or quarterly reportnone on EDGAR

Offerings

1 registration
RegistrationLabel and statusFirst filedLast eventFilings
333-299300
IPOFinal prospectus
 2026-10-052026-10-234

Filings

5
FiledFilingRegistrationAccession
2026-10-23424B4Final prospectus 333-2993000001628280-26-067048
2026-10-22EFFECTDeclared effective 333-2993009999999995-26-003321
2026-10-20S-1/AAmendment 333-2993000001628280-26-066381
2026-10-05S-1Registration filed 333-2993000001628280-26-064973
2026-07-02DRSDraft made public 377-095370001628279-26-000815

All filings of this company · CSV